Robert Lechleider - 27 Oct 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Medical Officer
Signature
/s/ Sandra G. Stoneman, Attorney-in-fact
Issuer symbol
IMNM
Transactions as of
27 Oct 2023
Net transactions value
$0
Form type
4
Filing time
31 Oct 2023, 18:30:54 UTC
Previous filing
20 Oct 2023
Next filing
13 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +400,000 $0.000000 400,000 27 Oct 2023 Common Stock 400,000 $8.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on October 16, 2024, and the remaining shares will vest monthly thereafter over three years.